发明名称 Microporous Zirconium Silicate for the Treatment of Hyperkalemia
摘要 The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of ZS-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
申请公布号 US2015250821(A1) 申请公布日期 2015.09.10
申请号 US201514628017 申请日期 2015.02.20
申请人 ZS Pharma, Inc. 发明人 KEYSER Donald Jeffrey;GUILLEM Alvaro F.
分类号 A61K33/24 主分类号 A61K33/24
代理机构 代理人
主权项 1. A zirconium silicate composition comprising zirconium silicate of formula (I): ApMxZr1-xSinGeyOm  (I) where A is a potassium ion, sodium ion, rubidium ion, cesium ion, calcium ion, magnesium ion, hydronium ion or mixtures thereof,M is at least one framework metal, wherein the framework metal is hafnium (4+), tin (4+), niobium (5+), titanium (4+), cerium (4+), germanium (4+), praseodymium (4+), terbium (4+) or mixtures thereof,“p” has a value from about 1 to about 20,“x” has a value from 0 to less than 1,“n” has a value from about 0 to about 12,“y” has a value from 0 to about 12, “m” has a value from about 3 to about 36 and 1≦n+y≦12, wherein the composition comprises ZS-9 and ZS-7 and lacks detectable amounts of ZS-8.
地址 Coppell TX US